Danny Hart
2016
In 2016, Danny Hart earned a total compensation of $1.4M as Vice President, Business Development at PDL BioPharma, a 4% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $655,903 |
|---|---|
| Salary | $381,924 |
| Stock Awards | $304,500 |
| Other | $40,000 |
| Total | $1,382,327 |
Hart received $655.9K in non-equity incentive plan, accounting for 47% of the total pay in 2016.
Hart also received $381.9K in salary, $304.5K in stock awards and $40K in other compensation.
Rankings
In 2016, Danny Hart's compensation ranked 6,657th out of 14,075 executives tracked by ExecPay. In other words, Hart earned more than 52.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,657 out of 14,075 | 53rd |
Division Manufacturing | 2,478 out of 5,486 | 55th |
Major group Chemicals And Allied Products | 808 out of 1,900 | 58th |
Industry group Drugs | 620 out of 1,543 | 60th |
Industry Biological Products, Except Diagnostic Substances | 114 out of 287 | 60th |
Source: SEC filing on April 28, 2017.
Hart's colleagues
We found four more compensation records of executives who worked with Danny Hart at PDL BioPharma in 2016.